Connect with us

INDUSTRIAL HEMP

Cannabis Science Inc (OTCMKTS:CBIS) On US Federal Government Clearance

Published

on

Cannabis Science Inc (OTCMKTS:CBIS) reported its support for the US Federal Government, and the organization intends to step in with its specialists to support the Federal Government. The firm is looking to set new Federal marijuana guideline and calls on DOJ to help develop a properly-regulated Federal Policy for patients’ safe access to pharma and pharmacy distributed cannabinoids for numerous critical ailments.

The details

Dr. Allen Herman, the Chief Medical Officer of Cannabis Science, expressed that as a research-based firm, the company’s focus is on pharma drug development and on developing drugs that can help people in need. They consider there are several indications that can be well treated with cannabinoid-based drugs and they project their research, development, and clinical study initiatives to exhibit this.

The U.S. Federal Government approval clearly positions Cannabis Science as one of the prime publicly traded firm in this market seeking to establish a Federal regulatory looking after body to arrange over the regulations, compliance and laws of the cannabis market. The company has also performed its operations in this way since the 2009 nod from the United States Federal Government as if these procedures and policies had been set at a Federal level.

Cannabis Science intends to work together with the establishment of federal regulations and laws, work within the federal regulations and laws that already prevail and with the federal organizations charged with administering them.

The CEO of Cannabis Science reported that the company is presently evaluating several Federal government deals and grant prospects, independently and with its collaborators, with firms like the National Institutes of Health, institutes within NIH, like the NIDA and others.

In the last trading session, the stock price of Cannabis Science declined more than 4% to close the day at $0.1092. The decline came at a share volume of 26.72 million compared to average share volume of 23.62 million.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement